THORN RUN PARTNERS

Lobbying for INSTITUTE FOR GENE THERAPIES · Advocacy organization

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Issues related to regulatory and reimbursement policies for innovative gene therapies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.